Dextran-70's Effect on Inflammation After Heart Surgery
Author Information
Author(s): Gombocz Károly, Beledi Ágnes, Alotti Nasri, Kecskés Gábor, Gábor Valéria, Bogár Lajos, Kőszegi Tamás, Garai János
Primary Institution: Zala County Hospital, University of Pécs, Hungary
Hypothesis
Administration of dextran reduces the level of inflammatory mediators and cardiac troponin-I at the most important timepoints.
Conclusion
The use of dextran-70 reduces the systemic inflammatory response and cardiac troponin-I release following cardiac operation.
Supporting Evidence
- Dextran-70 reduced peak procalcitonin levels compared to gelatin.
- Lower IL-8 and IL-10 levels were observed in the dextran group.
- Cardiac troponin-I levels were significantly lower in patients receiving dextran-70.
Takeaway
This study found that giving patients dextran-70 during heart surgery helps reduce inflammation and heart damage.
Methodology
A prospective, randomized, double-blind study with 40 patients undergoing cardiac surgery, comparing dextran-70 and gelatin.
Potential Biases
Potential bias due to the control group receiving gelatin, which may not be a neutral comparator.
Limitations
The study was conducted at a single institution and the control group received a colloid that may have anti-inflammatory effects.
Participant Demographics
40 patients, 32 undergoing coronary bypass surgery and 8 undergoing aortic valve replacement.
Statistical Information
P-Value
p < 0.001 for procalcitonin, IL 8, IL 10, and cardiac troponin-I.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website